Surveillance for Colonization, Transmission, and Infection With Methicillin-Susceptible Staphylococcus aureus in a Neonatal Intensive Care Unit.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 09 2021
Historique:
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 13 1 2022
Statut: epublish

Résumé

Staphylococcus aureus is one of the leading causes of infections in neonatal intensive care units (NICUs). Most studies in this patient group focus on methicillin-resistant S aureus or the outbreak setting, whereas data for methicillin-susceptible S aureus are limited. To identify risk factors for S aureus colonization and infections in hospitalized newborns and to investigate S aureus transmission and its dynamics in a nonoutbreak setting. This monocentric cohort study in a tertiary NICU in Heidelberg, Germany, enrolled all hospitalized neonates (n = 590) with at least 1 nasal screening swab positive for S aureus. Data were collected from January 1, 2018, to December 31, 2019. Weekly screening for S aureus colonization was performed for all newborns until discharge. The primary end point was any S aureus infection until hospital discharge. Transmission of S aureus and performance of routine typing to detect transmissions were defined as the secondary outcomes of the study. In total, 590 newborns were enrolled (276 [46.8%] female and 314 [53.2%] male; 220 [37.3%] with birthweight <1500 g; 477 [80.8%] preterm; 449 [76.1%] singletons; 419 [71.5%] delivered via cesarean section). The median length of stay was 26 (range, 10-62) days. Overall, 135 infants (22.9%) were colonized by S aureus at some time during their hospital stay. The median time to first detection was 17 (interquartile range, 11-37) days. The overall incidence of S aureus infection was 1.7% (10 of 590). Low birth weight (<1500 g [odds ratio, 9.3; 95% CI, 5.9-14.6; P < .001]) and longer hospital stay (odds ratio, 2.3; 95% CI, 1.9-2.7; P < .001) were associated with colonization. Nasal carriage was significantly associated with S aureus infection (odds ratio, 8.2; 95% CI, 2.1-32.3; P = .002). A total of 123 of 135 colonization isolates were sequenced. All recoverable infection isolates (4 of 7) of newborns with colonization were genetically identical to the colonizing isolate. Whole-genome sequencing indicated 23 potential transmission clusters. The findings of this cohort study suggest that nasal colonization is a relevant risk factor for S aureus infection in a nonoutbreak NICU setting. In colonized newborns, infection and colonization isolates were genetically identical, suggesting that eradication of colonization may be a useful measure to prevent infection. Further investigations are necessary to validate and assess the generalizability of our findings.

Identifiants

pubmed: 34515783
pii: 2783982
doi: 10.1001/jamanetworkopen.2021.24938
pmc: PMC8438598
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2124938

Références

Pediatrics. 2012 May;129(5):e1252-9
pubmed: 22473373
Lancet Infect Dis. 2017 Feb;17(2):207-214
pubmed: 27863959
Clin Microbiol Infect. 2014 Jun;20(6):O390-6
pubmed: 24118578
J Infect Dis. 2009 Jun 15;199(12):1820-6
pubmed: 19419332
Front Microbiol. 2018 Mar 20;9:511
pubmed: 29616014
N Engl J Med. 2001 Jan 4;344(1):11-6
pubmed: 11136954
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
JAMA. 2020 Jan 28;323(4):319-328
pubmed: 31886828
Infect Control Hosp Epidemiol. 2017 Jul;38(7):883-885
pubmed: 28514970
Pediatrics. 2006 Aug;118(2):469-74
pubmed: 16882797
Int J Infect Dis. 2017 Nov;64:9-14
pubmed: 28882667
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Arch Dis Child Fetal Neonatal Ed. 2019 Mar;104(2):F182-F186
pubmed: 29588296
JAMA Pediatr. 2015 Dec;169(12):1105-11
pubmed: 26502073
J Perinatol. 2021 Jun;41(6):1285-1292
pubmed: 33649431
JAMA. 2020 Jan 28;323(4):313-314
pubmed: 31886831
Clin Infect Dis. 2011 Nov;53(9):853-9
pubmed: 21878424
J Infect. 2020 May;80(5):511-518
pubmed: 32112885
Pediatr Infect Dis J. 2012 Apr;31(4):360-3
pubmed: 22189535
PLoS One. 2020 Feb 13;15(2):e0211845
pubmed: 32053585
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Clin Microbiol Infect. 2019 Jun;25(6):739-746
pubmed: 30315958
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1745-1751
pubmed: 29943308
J Perinatol. 2014 Nov;34(11):805-10
pubmed: 25010222
Infect Control Hosp Epidemiol. 2002 Nov;23(11):677-82
pubmed: 12452296
Microb Drug Resist. 2012 Apr;18(2):116-24
pubmed: 22191392
Sci Rep. 2020 Feb 14;10(1):2619
pubmed: 32060342
Am J Infect Control. 2011 Feb;39(1):35-41
pubmed: 21281885
Sci Rep. 2020 Aug 6;10(1):13243
pubmed: 32764618
Am J Dis Child. 1978 Sep;132(9):893-6
pubmed: 685907
BMJ Open. 2016 Oct 18;6(10):e010466
pubmed: 27797978
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Sci Rep. 2017 Mar 21;7:45014
pubmed: 28322345
Antimicrob Resist Infect Control. 2014 Jul 01;3:21
pubmed: 25089196
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Clin Microbiol Infect. 2015 Jun;21(6):567.e1-10
pubmed: 25753191

Auteurs

Dennis Nurjadi (D)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.

Vanessa M Eichel (VM)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.

Patrik Tabatabai (P)

Department of Neonatology, Heidelberg University Children's Hospital, Heidelberg, Germany.

Sabrina Klein (S)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.

Katharina Last (K)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.
Centre for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany.

Nico T Mutters (NT)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.
Institute for Hygiene and Public Health, Bonn University Hospital, Bonn, Germany.

Johannes Pöschl (J)

Department of Neonatology, Heidelberg University Children's Hospital, Heidelberg, Germany.

Philipp Zanger (P)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.

Klaus Heeg (K)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.

Sébastien Boutin (S)

Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH